Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Oncologie, a Boston, Massachusetts-headquartered biopharmaceutical company developing therapeutics in oncology, has formed an asset assignment and purchase agreement for Avid Bioservices’ phosphatidylserine (PS)-targeting program, including...

Colorcon, an excipient manufacturer, has launched a new film-coating system called Opadry EZ, Easy Swallow Film Coating System, to address difficulties swallowing oral solid-dosage forms. Source: Colorcon

Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization (CDMO), has appointed Bernard Pluta as president of development services to lead its new global development organization. Recipharm says the newly established...

MedPharm, a Guildford, England-headquartered provider of formulation and development services for topical and transdermal products, has invested £1 million ($1.4 million) to expand its formulation-development laboratories at its UK...

ABEC, a Bethlehem, Pennsylvania-based engineering, equipment, and services provider, has completed its second cleanroom for single-use disposable container (DC) manufacturing. ABEC’s Bethlehem-based cleanroom has been fully operational since 2015,...

LakePharma, a Belmont, California-based biologics company specializing in antibody and protein engineering, cell-line development, and protein production, has launched the LakePharma MicroBiomanufacturing Center in Hopkinton, Massachusetts. The...

Charles River Laboratories International, a Wilmington, Massachusetts-headquartered contract research organization (CRO), has agreed to acquire MPI Research, a Mattawan, Michigan-headquartered non-clinical contract research organization (CRO), for...

Lonza has launched a new product under its cell-culture product portfolio called the Quasi Vivo System. Lonza says the Quasi Vivo device consists of an interconnected fluidics system to create more physiologically relevant cell-culture conditions...

MilliporeSigma has launched its Viresolve Barrier capsule filters to reduce the risk of bioreactor contamination. Viresolve Barrier filters are designed to remove viruses, mycoplasma, and bacteria from cell-culture media. Viresolve Barrier filters...

Horizon Discovery Group, a Cambridge, UK-headquartered gene-editing technology company, has signed a non-exclusive out-licensing agreement with an undisclosed US-based immuno-oncology therapeutics developer, for Horizon’s proprietary technologies...